Percutaneous coronary artery intervention: The last five years and the next five years

American Heart Journal

Volumn 139, Issue 2 I, 2000, Pages 195-197

  Feit, F ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATHERECTOMY; CLINICAL PRACTICE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; EDITORIAL; HUMAN; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0033974666     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(00)90225-4     Document Type: Editorial

References (26)

1. Peterson ED, Lansky AJ, Anstrom KJ, et al. Evolving trends in interventional device use and outcomes: Results from the National Cardiovascular Network database. Am Heart J 2000;139:198-207.
2. Holubkov R, Detre KM, Sopko G, et al. Trends in coronary revascularization 1989 to 1997: The Bypass Angioplasty Revascularization Investigation (BARI) survey of procedures. Am J Cordial 1999;84:157-61.
3. Fischman DL, Leon MB, Balm DS, et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
4. Serruys P, de Jaegere P, Kiemeneij F, et al. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-95.
5. The EPISTENT Investigators. Randomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade. Lancet 1998;352:87-92.
6. Kimura T, Yokoi H, Tamura T, et al. Three years clinical and quantitative angiographic follow up after the Palmaz-Schotz coronary stent implantation [abstract]. J Am Coll Cardiol 1995;25:375A.
7. Detre K, Holubkov R, Kelsey S, et al. Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1971: The National Heart, Blood, Lung and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry. N Engl J Med 1988;318:265-70.
8. Topol E, Leya F, Pinkerton C, et al. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med 1993;329:221-7.
9. Balm DS, Kuntz RE, Sharma SK, et al. Acute results of the randomized phase of the balloon versus optimal atherectomy trial (BOAT) [abstract]. Circulation 1995;92:1-544.
10. Reisman M, Buchbinder M, Sharma SK, et al. A multicenter randomized trial of rotational atherectomy vs. PTCA: DART (abstract). Orlando (FL): American Heart Association.
11. Lee SG, Lee CW, Cheong SS et al. Immediate and long-term outcomes of rotational atherectomy versus balloon angioplasty alone for treatment of diffuse in-stent restenosis. Am J Cardiol 1998;82:140-3.
12. Leon MB, Baim DS, Popma J, et al A clinical trial comparing three antithrombotic drug regimens after coronary stenting. N Engl J Med 1998;339:1665-71.
13. Colombo A, Hall P, Matrini P, et al. Ultrasound-guided stenting without anticoagulation. In: Topol EJ, Serruys PW, editors. Current review of interventional cardiology, 2nd edition. Philadelphia: Current Medicine; 1995. p. 15.
14. Ellis SG. Coronary lesions at increased risk. Am Heart J 1995;130(3 Pt 2):643.6.
15. Bauters C, Banos JL, Van Belle E, et al. Six-month angiographic outcome after successful repeat percutaneous intervention for in-stent restenosis. Circulation 1998;97:318-21.
16. Tierstein PS, Massullo V, Shirish J, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997;336:1697-703.
17. Leon MB, Teirstein P, Lansky AJ, et al. Intracoronary gamma radiation to reduce in-stent restenosis: The Multicenter Gamma 1 Randomized Clinical Trial. J Am Coll Cardiol 1999;82 (suppl A):19A.
18. Weinberger J. Intracoronary radiation using radioisotope solution-filled balloons [abstract]. Herz 1998;23:366-72.
19. Fischell TA, Hehrein C. The radioisotope stent for the prevention of restenosis. Herz 1996;23:373-9.
20. Heuser RR, Woodfield S, Lopez A. Obliteration of coronary artery aneurysm with a PTFE-covered stent: endoluminal graft for coronary disease revisited. Cathet Cardiovasc Intervent 1999;46:113-6.
21. Veil KR, Chronos NAF, Palmer S J, et al. Phosphorylcholine: a biocompatible coating for coronary angioplasty devices [abstract]. Circulation 1999;92:-685.
22. De Gregorio CM, Di Maria C, Anzuini A, et al. Prevention of distal embolization during saphenous vein graft lesion angioplasty. Experience with a new temporary occlusion and aspiration system. Circulation 1999;99:3221-3.
23. Schofield PM, Sharpies LD, Caine N, et al. Transmyocardial laser revascularization in patients with refractory angina: a randomized controlled trial. Lancet 1999;353:519-24.
24. Schumacher B, Pecher P, van Specht BU, et al. Induction of neoangiogenesis in ischemic myocardium by human growth factors. First clinical results of a new treatment of coronary heart disease. Circulation 1998;97:645-50.
25. Giordano FJ, Ping P, McKirnan MD, et al. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat Med 1996;2:534-9.
26. Yeung AC, Hayase M, Fitzgerald P, et al. Percutaneous In-situ Coronary Artery Bypass (PICAB): Ccrrent development status and preliminary results of a novel myocardial revascularization technique [abstract]. J Am Coll Cardiol 1999;33(suppl A):47A.